Dr. Xiaobing LI
Dr. Xiaobing Li is the Chief Business Officer of InvivoGen Asia-Pacific. As the leader of an international team from China, France, Korea and India, Dr. Li aims at developing business opportunities and providing professional support to life science researchers in the Asia-Pacific region.
SEPTEMBER 17TH: ONE HEALTH @ CITYU X FRANCE
Dr. Xiaobing Li will be participating in "The Potential of Biotechnology in Tackling Global Challenges" on September 17th (Fri) as part of ONE HEALTH @ CITYU X FRANCE. Tune in to the discussion from 4:15 - 5:15 PM (HK time).
Register here.
Speaker Profile
Dr. Xiaobing Li, Ph.D.
Chief Business Officer, InvivoGen Asia-Pacific
Dr. Xiaobing Li is the Chief Business Officer of InvivoGen Asia-Pacific. Dr. Li moved to Hong Kong and joined InvivoGen Asia-Pacific as technical sales specialist in 2015. He was in charge of business development, distributor management, marketing and key account management of Asia-Pacific regional market. Dr. Li brought the volume of China sales, which was the third ranking in Asia-Pacific in 2015, up to the second largest of InvivoGen global in 2018. Dr. Li became the Chief Business Officer of InvivoGen Asia-Pacific in 2019. As the leader of an international team from China, France, Korea and India, Dr. Li aims at developing business opportunities and providing professional support to life science researchers in Asian-Pacific region.
Prior to joining InvivoGen, Xiaobing Li received his Ph.D. from the University of Tokyo. He focused on mechanisms of innate immune sensor response during doctor courses and postdoc fellowship, which are both trained by Prof. Miyake Kensuke, a pioneer scientist in innate immunity.